Clinical Trial Update: Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing pimavanserin with quetiapine for treatment of Parkinson disease psychosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease Psychosis

Drugs mentioned

• Pimavanserin (pimavanserin)
• Quetiapine (quetiapine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Parkinson's Disease Psychosis | Phase 4 | Status: RECRUITING